Glaukos’s iStent Inject is designed to reduce intraocular pressure safely and effectively in patients who have been diagnosed with primary open-angle glaucoma, pseudo-exfoliative glaucoma or pigmentary glaucoma.
The injection is implanted through a single-entry point during cataract surgery or during a standalone procedure. It creates a bypass through the primary blockage site to improve physiological outflow, according to the company.
Glaukos’s iStent Inject system features two preloaded stents in a single-use sterile inserter. With a central inlet and four outlets, the iStent Inject optimizes flow and collector channel access. The preloaded inserted is made with a cam drive to implant two stents and the insertion tube features a window to optimize visualization during implantation. A trocar tip easily guides the implants through the trabecular meshwork.